IndoStar Capital Finance Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32
INDOSTAR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
IndoStar Capital Finance has filed a routine compliance statement under SEBI's Listing Regulations confirming NIL deviation in the use of funds raised from two preferential issues of convertible warrants. The first issue in May 2024 involved 1.08 crore warrants at ₹184 each (total ~₹200 crore), and the second in November 2024 involved 1.39 crore warrants at ₹184 each (total ~₹256.67 crore). No new funds were raised during the quarter ended June 30, 2025. For the November 2024 issue, the company used 80% of the proceeds for growth/lending objectives, which is above the minimum 75% committed in the offer document. CRISIL Ratings Limited is the monitoring agency for both issues.
This is a routine, neutral regulatory disclosure with no material impact on shareholders or the stock. It simply confirms that the company is using warrant-issue proceeds as originally promised to investors, which supports governance credibility.